Skip to content
Screener

GoodRx Holdings, Inc. GDRX Q2 2026 earnings

Reported August 5, 2026 · After market close

Revenue$200.4MBeat by $7.2M
EPS$0.08Beat by $0.00
Revenue estimate$193.2M
EPS estimate$0.08
“We believe this progress is accelerating our return to growth and strengthening the long-term durability of GoodRx.”
Wendy Barnes

Next report

Nov 3, 2026 (In 3 weeks)
Revenue estimate$201.9M
EPS estimate$0.08

Financials

Q2 2026

Income statement

See full
Revenue$200.4M-1.3%
Gross profit$179.4M-5.4%
Operating income$23.6M-11.9%
Net income$8.5M-33.5%
EPS (diluted)$0.02-50.0%

Balance sheet

See full
Cash & equivalents$296.1M+5.3%
Total debt$539.0M-1.6%
Total equity$647.6M+0.7%
Total assets$2.3B+77.7%

Cash flow

See full
Operating cash flow$80.8M+63.0%
CapEx$362.0K-7.2%
Free cash flow$80.5M+63.6%

Valuation & ratios

Valuation

as of 10/09/26
See full
Market cap$1.15B-28.9%
Enterprise value$1.39B-26.3%
P/E70.5×+19.8×
P/S1.5×-0.6×

Profitability

See full
Gross margin90.8%-2.8pp
Operating margin9.5%-1.6pp
Net margin2.1%-2.3pp
FCF margin25.1%+1.4pp

Returns & leverage

See full
Return on equity2.5%-2.8pp
Debt / equity0.8×0.0×
Current ratio1.4×-2.8×

Segments

By product

See full
Prescription transactions revenue$106.4M-25.6%
Pharma Direct revenue$61.6M+76.2%
Subscription revenue$28.5M+39.3%
Other revenue$3.9M-15.0%

FAQ

When did GoodRx Holdings, Inc. report Q2 2026 earnings?
GoodRx Holdings, Inc. (GDRX) reported Q2 2026 earnings on August 5, 2026 after market close.
What were GoodRx Holdings, Inc.'s Q2 2026 revenue and EPS?
GoodRx Holdings, Inc. reported revenue of $200.4M and eps of $0.08 for Q2 2026.
Did GoodRx Holdings, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $193.2M by $7.2M. EPS beat the consensus estimate of $0.08 by $0.00.
How did GoodRx Holdings, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.3% from $203.1M a year earlier and eps declined 11.1% from $0.09.
Where can I find GoodRx Holdings, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001809519-26-000151) and the 10-Q periodic report (0001809519-26-000152) directly on SEC EDGAR. The filing index links above go to sec.gov.